Merus_October_2022_210_88210

Loading viewer...

investor_presentation

Format: PDF investor_presentation

This investor presentation provides an update on Merus's MCLA-129, highlighting its potential impact on cancer treatment and clinical trial progress.

Your message matters.

Let us design a presentation that delivers.

presentation

presentation

AAC Technologies Holdings Investor Presentation — August 2018

10 Pages

AAC Technologies Holdings Inc.

Regeneron Pharmaceuticals Investor Presentation — May 2022